$CHCI
Comstock Holding Companies, Inc.

2015 Q2 Form 10-Q Financial Statement

#000119312515291714 Filed on August 14, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2014 Q2
Revenue $12.56M $11.80M
YoY Change 6.47% -3.38%
Cost Of Revenue $10.80M $9.500M
YoY Change 13.68% -4.04%
Gross Profit $1.782M $2.256M
YoY Change -21.01% -2.59%
Gross Profit Margin 14.18% 19.12%
Selling, General & Admin $2.425M $2.877M
YoY Change -15.71% 29.89%
% of Gross Profit 136.08% 127.53%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $94.00K $24.00K
YoY Change 291.67% -80.17%
% of Gross Profit 5.27% 1.06%
Operating Expenses $2.425M $2.877M
YoY Change -15.71% 29.89%
Operating Profit -$799.0K -$624.0K
YoY Change 28.04% 3570.59%
Interest Expense $154.0K $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $582.0K $12.00K
YoY Change 4750.0% -90.84%
Pretax Income -$217.0K -$612.0K
YoY Change -64.54% -636.84%
Income Tax $57.00K $57.00K
% Of Pretax Income
Net Earnings -$808.0K -$1.664M
YoY Change -51.44% 98.57%
Net Earnings / Revenue -6.43% -14.1%
Basic Earnings Per Share -$0.25 -$0.55
Diluted Earnings Per Share -$0.25 -$0.55
COMMON SHARES
Basic Shares Outstanding 3.173M shares 21.09M shares
Diluted Shares Outstanding 3.173M shares 21.09M shares

Balance Sheet

Concept 2015 Q2 2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.200M $4.800M
YoY Change 29.17% -57.89%
Cash & Equivalents $6.152M $4.814M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $1.000M $1.300M
Other Receivables $0.00 $0.00
Total Short-Term Assets $7.200M $6.100M
YoY Change 18.03% -53.44%
LONG-TERM ASSETS
Property, Plant & Equipment $478.0K $202.0K
YoY Change 136.63% -24.06%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.200M $3.000M
YoY Change -26.67% -16.67%
Total Long-Term Assets $54.81M $49.41M
YoY Change 10.94% 42.86%
TOTAL ASSETS
Total Short-Term Assets $7.200M $6.100M
Total Long-Term Assets $54.81M $49.41M
Total Assets $62.01M $55.51M
YoY Change 11.72% 16.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.500M $10.80M
YoY Change -12.04% 47.95%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $49.00M $31.90M
YoY Change 53.61% 29.67%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $58.50M $42.70M
YoY Change 37.0% 33.86%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $58.50M $42.70M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $58.51M $42.76M
YoY Change 36.83% 34.07%
SHAREHOLDERS EQUITY
Retained Earnings -$173.0M -$167.6M
YoY Change 3.19% 3.17%
Common Stock $172.8M $171.0M
YoY Change 1.01% 0.28%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.644M $1.134M
YoY Change
Total Liabilities & Shareholders Equity $62.01M $55.51M
YoY Change 11.72% 16.41%

Cashflow Statement

Concept 2015 Q2 2014 Q2
OPERATING ACTIVITIES
Net Income -$808.0K -$1.664M
YoY Change -51.44% 98.57%
Depreciation, Depletion And Amortization $94.00K $24.00K
YoY Change 291.67% -80.17%
Cash From Operating Activities -$1.800M -$700.0K
YoY Change 157.14% -46.15%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities -$100.0K -$100.0K
YoY Change 0.0%
Cash From Investing Activities -$200.0K -$100.0K
YoY Change 100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.700M -1.800M
YoY Change -250.0% -154.55%
NET CHANGE
Cash From Operating Activities -1.800M -700.0K
Cash From Investing Activities -200.0K -100.0K
Cash From Financing Activities 2.700M -1.800M
Net Change In Cash 700.0K -2.600M
YoY Change -126.92% -230.0%
FREE CASH FLOW
Cash From Operating Activities -$1.800M -$700.0K
Capital Expenditures $0.00 $0.00
Free Cash Flow -$1.800M -$700.0K
YoY Change 157.14% -41.67%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
514000
CY2015Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
362000
CY2014Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
722000
CY2014Q2 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2014Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
12747000
CY2014Q2 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
4300000
CY2014Q2 us-gaap Assets
Assets
55506000
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4814000
CY2014Q2 chci Accrued Liability Settled Through Issuance Of Stock
AccruedLiabilitySettledThroughIssuanceOfStock
162000
CY2014Q3 us-gaap Loans Receivable With Fixed Rates Of Interest1
LoansReceivableWithFixedRatesOfInterest1
180000
CY2015Q2 us-gaap Variable Interest Entity Consolidated Carrying Amount Liabilities
VariableInterestEntityConsolidatedCarryingAmountLiabilities
17900000
CY2015Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
172751000
CY2015Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
9619000
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
-2644000
CY2014Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
8538000
CY2014Q4 us-gaap Notes Payable
NotesPayable
45931000
CY2015Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
62009000
CY2015Q2 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2015Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3501000
CY2015Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
23255000
CY2015Q2 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
17938000
CY2015Q2 us-gaap Unsecured Debt
UnsecuredDebt
1806000
CY2015Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
2970000
CY2015Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-172969000
CY2015Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
294000
CY2015Q2 us-gaap Liabilities
Liabilities
58508000
CY2015Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
13198000
CY2015Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
4000000
CY2014Q4 us-gaap Minority Interest
MinorityInterest
3986000
CY2014Q4 us-gaap Liabilities
Liabilities
54512000
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
56367000
CY2015Q2 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
9466000
CY2015Q2 us-gaap Notes Payable
NotesPayable
49042000
CY2015Q2 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
3700000
CY2015Q2 us-gaap Minority Interest
MinorityInterest
6145000
CY2015Q2 us-gaap Secured Debt
SecuredDebt
29298000
CY2015Q2 us-gaap Debt Current
DebtCurrent
23300000
CY2015Q2 us-gaap Line Of Credit
LineOfCredit
2200000
CY2015Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
300000
CY2015Q2 us-gaap Variable Interest Entity Consolidated Carrying Amount Assets
VariableInterestEntityConsolidatedCarryingAmountAssets
26000000
CY2015Q2 us-gaap Assets
Assets
62009000
CY2015Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
48000000
CY2015Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2152000
CY2015Q2 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
47058000
CY2015Q2 us-gaap Escrow Deposit
EscrowDeposit
600000
CY2015Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
478000
CY2015Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
954000
CY2015Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
2200000
CY2015Q2 us-gaap Notes Receivable Gross
NotesReceivableGross
157000
CY2015Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
123000000
CY2015Q2 us-gaap Other Assets
OtherAssets
5215000
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6152000
CY2015Q2 chci Accrued Liability Settled Through Issuance Of Stock
AccruedLiabilitySettledThroughIssuanceOfStock
50000
CY2013Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
510000
CY2013Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
19059000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11895000
CY2014Q4 us-gaap Variable Interest Entity Consolidated Carrying Amount Liabilities
VariableInterestEntityConsolidatedCarryingAmountLiabilities
13500000
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
171452000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
-2131000
CY2014Q4 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
15488000
CY2014Q4 us-gaap Unsecured Debt
UnsecuredDebt
2064000
CY2014Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
43000
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-171218000
CY2014Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
492000
CY2014Q4 us-gaap Secured Debt
SecuredDebt
28379000
CY2014Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
500000
CY2014Q4 us-gaap Variable Interest Entity Consolidated Carrying Amount Assets
VariableInterestEntityConsolidatedCarryingAmountAssets
19500000
CY2014Q4 us-gaap Assets
Assets
56367000
CY2014Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1779000
CY2014Q4 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
40889000
CY2014Q4 us-gaap Escrow Deposit
EscrowDeposit
400000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
395000
CY2014Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
110000
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1855000
CY2014Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
1400000
CY2014Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
173000
CY2014Q4 us-gaap Other Assets
OtherAssets
5696000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7498000
CY2014Q4 us-gaap Debt Instrument Redemption Price Percentage Of Principal Amount Redeemed
DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed
0.10 pure
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-3304000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1010000 shares
us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
-132000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21012000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21012000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
us-gaap Other Real Estate Period Increase Decrease
OtherRealEstatePeriodIncreaseDecrease
-3528000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
11290000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7000
us-gaap Net Income Loss
NetIncomeLoss
-3243000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
62000
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
344000
us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
132000
us-gaap Profit Loss
ProfitLoss
-1512000
us-gaap Other Real Estate Revenue
OtherRealEstateRevenue
266000
us-gaap Operating Income Loss
OperatingIncomeLoss
-1448000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
880000
us-gaap Home Building Revenue
HomeBuildingRevenue
19488000
us-gaap Interest Income Other
InterestIncomeOther
0
us-gaap Gross Profit
GrossProfit
3861000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
67000
us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
296000
us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
45000
us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
73000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
202000
us-gaap Real Estate Revenue Net
RealEstateRevenueNet
19754000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
963000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
274000
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
5012000
us-gaap Interest Paid Net
InterestPaidNet
417000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
37000
us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
-29000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1381000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
131000
us-gaap Share Based Compensation
ShareBasedCompensation
96000
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
66000
us-gaap Equity Method Investment Summarized Financial Information Cost Of Sales
EquityMethodInvestmentSummarizedFinancialInformationCostOfSales
59000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1097000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
142000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-209000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-3568000
us-gaap Cash And Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-7081000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3447000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4207000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-313000
us-gaap Real Estate Tax Expense
RealEstateTaxExpense
56000
us-gaap Home Building Costs
HomeBuildingCosts
15715000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
416000
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
5012000
us-gaap Interest Costs Incurred
InterestCostsIncurred
1080000
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
178000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
12841000
us-gaap Depreciation
Depreciation
48000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
48000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1731000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
5000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
10000
chci Allocated Share Based Compensation Expense Benefit
AllocatedShareBasedCompensationExpenseBenefit
112000
chci Interest And Real Estate Taxes Expensed As Component Of Cost Of Sales
InterestAndRealEstateTaxesExpensedAsComponentOfCostOfSales
197000
chci Ordinary Shares Withheld Under Share Based Compensation Value
OrdinarySharesWithheldUnderShareBasedCompensationValue
62000
chci Interest Expensed As Component Of Cost Of Sales
InterestExpensedAsComponentOfCostOfSales
141000
chci Interest And Real Estate Taxes Incurred And Capitalized
InterestAndRealEstateTaxesIncurredAndCapitalized
1184000
chci Real Estate Taxes Incurred And Capitalized
RealEstateTaxesIncurredAndCapitalized
104000
chci Real Estate Taxes Incurred And Expensed For Inactive Projects Net
RealEstateTaxesIncurredAndExpensedForInactiveProjectsNet
5000
chci Increase In Class Common Stock Par Value In Connection With Issuance Of Stock Compensation
IncreaseInClassCommonStockParValueInConnectionWithIssuanceOfStockCompensation
2000
chci Amounts Drawn Against Outstanding Letters Of Credit Or Performance Bonds
AmountsDrawnAgainstOutstandingLettersOfCreditOrPerformanceBonds
0
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-5573000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 Segment
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Amendment Flag
AmendmentFlag
false
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
111000 shares
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001299969
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y4M24D
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Registrant Name
EntityRegistrantName
Comstock Holding Companies, Inc.
us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
-290000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21544000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21544000 shares
dei Document Period End Date
DocumentPeriodEndDate
2015-06-30
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Use of Estimates</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> Our financial statements have been prepared in accordance with GAAP. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts for the reporting periods. We base these estimates and judgments on historical experience and on various other factors that we believe to be reasonable under the circumstances. On an ongoing basis, we evaluate these estimates and judgments. Actual results may differ from those estimates under different assumptions or conditions.</p> </div>
dei Trading Symbol
TradingSymbol
CHCI
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
us-gaap Other Real Estate Period Increase Decrease
OtherRealEstatePeriodIncreaseDecrease
-6152000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
15377000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
136000
us-gaap Net Income Loss
NetIncomeLoss
-1751000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
32000
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
92000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1107000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
269000
us-gaap Derivative Gain On Derivative
DerivativeGainOnDerivative
696000
us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
172000
us-gaap Profit Loss
ProfitLoss
-942000
us-gaap Other Real Estate Revenue
OtherRealEstateRevenue
756000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
79000
us-gaap Operating Income Loss
OperatingIncomeLoss
-1729000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-470000
us-gaap Home Building Revenue
HomeBuildingRevenue
22125000
us-gaap Interest Income Other
InterestIncomeOther
2000
us-gaap Gross Profit
GrossProfit
3344000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
774000
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
243000
us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
121000
us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
92000
us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
107000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
252000
us-gaap Real Estate Revenue Net
RealEstateRevenueNet
22881000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
723000
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
1100000
us-gaap Interest Paid Net
InterestPaidNet
-30000
us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
2450000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
54000
us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
19000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-955000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-13000
us-gaap Share Based Compensation
ShareBasedCompensation
135000
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
35000
us-gaap Equity Method Investment Summarized Financial Information Cost Of Sales
EquityMethodInvestmentSummarizedFinancialInformationCostOfSales
65000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
914000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
181000
us-gaap Restructuring Charges
RestructuringCharges
0
us-gaap Interest Expense
InterestExpense
321000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-372000
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
16000
us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
317000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
4599000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-90000
us-gaap Cash And Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1346000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2036000
us-gaap Notes Reduction
NotesReduction
543000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3833000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-43000
us-gaap Real Estate Tax Expense
RealEstateTaxExpense
92000
us-gaap Home Building Costs
HomeBuildingCosts
19184000
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
2450000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
338000
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
1100000
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
79000
us-gaap Interest Costs Incurred
InterestCostsIncurred
1627000
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
353000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
18829000
us-gaap Depreciation
Depreciation
53000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
205000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
809000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
326000
chci Debt Instrument Maturity Year
DebtInstrumentMaturityYear
2015
chci Allocated Share Based Compensation Expense Benefit
AllocatedShareBasedCompensationExpenseBenefit
152000
chci Interest And Real Estate Taxes Expensed As Component Of Cost Of Sales
InterestAndRealEstateTaxesExpensedAsComponentOfCostOfSales
848000
chci Stockholders Rights Plan Expiration Month And Year
StockholdersRightsPlanExpirationMonthAndYear
2014-05
chci Separation Agreement Date
SeparationAgreementDate
2014-06-24
chci Ordinary Shares Withheld Under Share Based Compensation Value
OrdinarySharesWithheldUnderShareBasedCompensationValue
33000
chci Maturity Date Of Note Receivable
MaturityDateOfNoteReceivable
2019-09-02
chci Period For Which Warranty Claims Expected To Arise Under Statutorily Period
PeriodForWhichWarrantyClaimsExpectedToAriseUnderStatutorilyPeriod
P2Y
chci Net Operating Loss Carry Forward Expiration Year Begin
NetOperatingLossCarryForwardExpirationYearBegin
2028
chci Interest Incurred And Expensed For Inactive Projects Net
InterestIncurredAndExpensedForInactiveProjectsNet
4000
chci Period For Which Warranty Claims Expected To Arise
PeriodForWhichWarrantyClaimsExpectedToArise
P1Y
chci Interest Expensed As Component Of Cost Of Sales
InterestExpensedAsComponentOfCostOfSales
756000
chci Interest And Real Estate Taxes Incurred And Capitalized
InterestAndRealEstateTaxesIncurredAndCapitalized
1816000
chci Change In Ownership Of Shareholders In Specified Time
ChangeInOwnershipOfShareholdersInSpecifiedTime
P3Y
chci Real Estate Taxes Incurred And Capitalized
RealEstateTaxesIncurredAndCapitalized
189000
chci Debt Discount Amortization Period
DebtDiscountAmortizationPeriod
P3Y
chci Agreement Expiration Date
AgreementExpirationDate
2015-06-30
chci Interest Rate On Notes Receivable
InterestRateOnNotesReceivable
0.06 pure
chci Real Estate Taxes Incurred And Expensed For Inactive Projects Net
RealEstateTaxesIncurredAndExpensedForInactiveProjectsNet
5000
chci Increase In Class Common Stock Par Value In Connection With Issuance Of Stock Compensation
IncreaseInClassCommonStockParValueInConnectionWithIssuanceOfStockCompensation
2000
CY2014Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
995000
CY2014Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
3000
CY2014Q2 chci Allocated Share Based Compensation Expense Benefit
AllocatedShareBasedCompensationExpenseBenefit
-38000
CY2014Q2 chci Interest And Real Estate Taxes Expensed As Component Of Cost Of Sales
InterestAndRealEstateTaxesExpensedAsComponentOfCostOfSales
114000
chci Amounts Drawn Against Outstanding Letters Of Credit Or Performance Bonds
AmountsDrawnAgainstOutstandingLettersOfCreditOrPerformanceBonds
0
CY2014 us-gaap Profit Loss
ProfitLoss
-3100000
CY2014 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
14600000
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2014Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
822000 shares
CY2014Q2 us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
-98000
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21089000 shares
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21089000 shares
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-1664000
CY2014Q2 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
306000
CY2014Q2 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
71000
CY2014Q2 us-gaap Profit Loss
ProfitLoss
-669000
CY2014Q2 us-gaap Other Real Estate Revenue
OtherRealEstateRevenue
143000
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-624000
CY2014Q2 us-gaap Home Building Revenue
HomeBuildingRevenue
11657000
CY2014Q2 us-gaap Interest Income Other
InterestIncomeOther
0
CY2014Q2 us-gaap Gross Profit
GrossProfit
2256000
CY2014Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
12000
CY2014Q2 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
41000
CY2014Q2 us-gaap Real Estate Revenue Net
RealEstateRevenueNet
11800000
CY2014Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
21000
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-612000
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
57000
CY2014Q2 us-gaap Equity Method Investment Summarized Financial Information Cost Of Sales
EquityMethodInvestmentSummarizedFinancialInformationCostOfSales
30000
CY2014Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
559000
CY2014Q2 us-gaap Health Care Organization Expenses Net
HealthCareOrganizationExpensesNet
14000
CY2014Q2 us-gaap Severance Costs1
SeveranceCosts1
597000
CY2014Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2318000
CY2014Q2 us-gaap Real Estate Tax Expense
RealEstateTaxExpense
25000
CY2014Q2 us-gaap Home Building Costs
HomeBuildingCosts
9459000
CY2014Q2 us-gaap Interest Costs Incurred
InterestCostsIncurred
551000
CY2014Q2 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
85000
CY2014Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
131000
CY2014Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
24000
CY2015Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22217000 shares
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2015Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
582000
CY2014Q2 chci Number Of Semi Monthly Installment
NumberOfSemiMonthlyInstallment
36 Installment
CY2014Q2 chci Interest Expensed As Component Of Cost Of Sales
InterestExpensedAsComponentOfCostOfSales
89000
CY2014Q2 chci Interest And Real Estate Taxes Incurred And Capitalized
InterestAndRealEstateTaxesIncurredAndCapitalized
602000
CY2014Q2 chci Real Estate Taxes Incurred And Capitalized
RealEstateTaxesIncurredAndCapitalized
51000
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-808000
CY2015Q2 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
50000
CY2015Q2 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
98000
CY2014Q2 chci Real Estate Taxes Incurred And Expensed For Inactive Projects Net
RealEstateTaxesIncurredAndExpensedForInactiveProjectsNet
3000
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2015Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
36000 shares
CY2015Q2 us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
-118000
CY2015Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22217000 shares
CY2015Q2 us-gaap Profit Loss
ProfitLoss
-274000
CY2015Q2 us-gaap Other Real Estate Revenue
OtherRealEstateRevenue
449000
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-799000
CY2015Q2 us-gaap Home Building Revenue
HomeBuildingRevenue
12115000
CY2015Q2 us-gaap Interest Income Other
InterestIncomeOther
5000
CY2015Q2 us-gaap Gross Profit
GrossProfit
1782000
CY2015Q2 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
70000
CY2015Q2 us-gaap Real Estate Revenue Net
RealEstateRevenueNet
12564000
CY2015Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
35000
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-217000
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
57000
CY2015Q2 us-gaap Equity Method Investment Summarized Financial Information Cost Of Sales
EquityMethodInvestmentSummarizedFinancialInformationCostOfSales
28000
CY2015Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
489000
CY2015Q2 us-gaap Interest Expense
InterestExpense
154000
CY2015Q2 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
154000
CY2015Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1936000
CY2015Q2 us-gaap Real Estate Tax Expense
RealEstateTaxExpense
54000
CY2015Q2 us-gaap Home Building Costs
HomeBuildingCosts
10594000
CY2015Q2 us-gaap Interest Costs Incurred
InterestCostsIncurred
866000
CY2015Q2 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
188000
CY2015Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
94000
CY2015Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
534000
CY2015Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
156000
CY2015Q2 chci Allocated Share Based Compensation Expense Benefit
AllocatedShareBasedCompensationExpenseBenefit
67000
CY2015Q2 chci Interest And Real Estate Taxes Expensed As Component Of Cost Of Sales
InterestAndRealEstateTaxesExpensedAsComponentOfCostOfSales
430000
CY2015Q2 chci Interest Expensed As Component Of Cost Of Sales
InterestExpensedAsComponentOfCostOfSales
376000
CY2015Q2 chci Interest And Real Estate Taxes Incurred And Capitalized
InterestAndRealEstateTaxesIncurredAndCapitalized
987000
CY2015Q2 chci Real Estate Taxes Incurred And Capitalized
RealEstateTaxesIncurredAndCapitalized
121000
CY2015Q2 chci Real Estate Taxes Incurred And Expensed For Inactive Projects Net
RealEstateTaxesIncurredAndExpensedForInactiveProjectsNet
2000

Files In Submission

Name View Source Status
0001193125-15-291714-index-headers.html Edgar Link pending
0001193125-15-291714-index.html Edgar Link pending
0001193125-15-291714.txt Edgar Link pending
0001193125-15-291714-xbrl.zip Edgar Link pending
chci-20150630.xml Edgar Link completed
chci-20150630.xsd Edgar Link pending
chci-20150630_cal.xml Edgar Link unprocessable
chci-20150630_def.xml Edgar Link unprocessable
chci-20150630_lab.xml Edgar Link unprocessable
chci-20150630_pre.xml Edgar Link unprocessable
d948784d10q.htm Edgar Link pending
d948784dex1096.htm Edgar Link pending
d948784dex31.htm Edgar Link pending
d948784dex311.htm Edgar Link pending
d948784dex312.htm Edgar Link pending
d948784dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending